UK’s Labour to hold talks with other parties on election timing
Britain’s opposition Labour Party will hold talks with other opposition parties to discuss its support, and a possible date, for a general election, its foreign...
UK Labour leader to discuss election and Brexit tactics with allies
Britain’s opposition Labour Party leader Jeremy Corbyn will hold a conference call with other opposition parties on Friday to discuss plans to prevent a no-deal...
Taliban attack Afghan province as violence overshadows peace deal
Taliban militants launched a major attack in Afghanistan’s western province of Farah on Friday, the latest in a series of assaults on provincial centers just...
Attackers kill two aid workers in western Ethiopia: aid group, U.N.
Unidentified attackers killed two aid workers who were returning from a refugee camp in an western Ethiopia region that shares a border with South Sudan,...
Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful
Novartis has nabbed the U.S. Food and Drug Administration’s breakthrough therapy designation for its experimental medicine capmatinib as it joins Pfizer in the race to...
Timeline: A look at the life of Zimbabwe’s late president Robert Mugabe
Following are key milestones in the life of Zimbabwe’s former leader Robert Mugabe....
Former Zimbabwe president Robert Mugabe dead at 95
Robert Mugabe, the guerrilla leader who led Zimbabwe to independence in 1980 and ruled with an iron fist until his own army ended his almost...
Lao activist latest asylum-seeker to go missing in Thailand: right groups
A political activist from Laos who fled to Thailand has gone missing after seeking refugee status with the United Nations, the latest in a series...
Inside drugmakers’ strategy to boost cancer medicines with ‘Lazarus effect’
In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect” in some patients because it can reverse...
Novartis wins FDA’s breakthrough tag for lung cancer hopeful
Novartis has secured the U.S. Food and Drug Administration’s Breakthrough Therapy Designation for its investigational medicine capmatinib, which it aims to file for approval later...